These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30662920)

  • 1. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.
    Nezos A; Gkioka E; Koutsilieris M; Voulgarelis M; Tzioufas AG; Mavragani CP
    J Immunol Res; 2018; 2018():6923213. PubMed ID: 30662920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma.
    Nocturne G; Tarn J; Boudaoud S; Locke J; Miceli-Richard C; Hachulla E; Dubost JJ; Bowman S; Gottenberg JE; Criswell LA; Lessard CJ; Sivils KL; Carapito R; Bahram S; Seror R; Ng WF; Mariette X
    Ann Rheum Dis; 2016 Apr; 75(4):780-3. PubMed ID: 26338037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
    Ciccacci C; Latini A; Perricone C; Conigliaro P; Colafrancesco S; Ceccarelli F; Priori R; Conti F; Perricone R; Novelli G; Borgiani P
    J Immunol Res; 2019; 2019():6728694. PubMed ID: 31534975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome.
    Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Maiorano E; D'Amore M
    Histochem Cell Biol; 2011 Jun; 135(6):615-25. PubMed ID: 21604024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.
    Nocturne G; Boudaoud S; Miceli-Richard C; Viengchareun S; Lazure T; Nititham J; Taylor KE; Ma A; Busato F; Melki J; Lessard CJ; Sivils KL; Dubost JJ; Hachulla E; Gottenberg JE; Lombès M; Tost J; Criswell LA; Mariette X
    Blood; 2013 Dec; 122(25):4068-76. PubMed ID: 24159176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.
    Nordmark G; Wang C; Vasaitis L; Eriksson P; Theander E; Kvarnström M; Forsblad-d'Elia H; Jazebi H; Sjöwall C; Reksten TR; Brun JG; Jonsson MV; Johnsen SJ; Wahren-Herlenius M; Omdal R; Jonsson R; Bowman S; Ng WF; Eloranta ML; Syvänen AC;
    Scand J Immunol; 2013 Nov; 78(5):447-54. PubMed ID: 23944604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional variants of TNFAIP3 are associated with systemic lupus erythematosus in a cohort of Chinese Han population.
    Xu M; Gao W; Wu L; Liu X; Yu D; Shi X; Liu X; Wang Q; Fu X; Yu J; Xu B; Wang S
    Hum Immunol; 2019 Feb; 80(2):140-145. PubMed ID: 30529365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.
    Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R
    Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
    Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
    Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.
    Argyriou E; Nezos A; Roussos P; Venetsanopoulou A; Voulgarelis M; Boki K; Tzioufas AG; Moutsopoulos HM; Mavragani CP
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33567548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the cytoplasmic ubiquitin ligase TNFAIP3 gene variation on transcription factor NF-κB activation in acute kidney injury.
    Rogers NM; Zammit N; Nguyen-Ngo D; Souilmi Y; Minhas N; Meijles DN; Self E; Walters SN; Warren J; Cultrone D; El-Rashid M; Li J; Chtanova T; O'Connell PJ; Grey ST
    Kidney Int; 2023 Jun; 103(6):1105-1119. PubMed ID: 37097268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association studies of TNFSF4, TNFAIP3 and FAM167A-BLK polymorphisms with primary Sjogren's syndrome in Han Chinese.
    Sun F; Li P; Chen H; Wu Z; Xu J; Shen M; Leng X; Shi Q; Zhang W; Tian X; Li Y; Zhang F
    J Hum Genet; 2013 Jul; 58(7):475-9. PubMed ID: 23635951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Pathology; 2012 Oct; 44(6):557-61. PubMed ID: 22935973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Xinfeng Capsule reduces hypercoagulative state in patients with Sjogren's syndrome by inhibiting miR-155/SOCS1/NF-κB signaling pathway].
    Zhu F; Liu J; Wang G; Fang L; Zhang P; Tan B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1366-1371. PubMed ID: 27667464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
    J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.
    Liu M; Wu X; Liu X; He J; Su Y; Guo J; Li Z
    Hum Immunol; 2015 Nov; 76(11):808-11. PubMed ID: 26429306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.